Atlas
Back to Pharma Services
Target·Pharma Services

Johnson & Johnson

New Brunswick, USAjnj.com1expert edge

Largest pharma company by market cap; spun off Kenvue consumer health business in May 2023 via IPO raising $3.8B, allowing focus on pharmaceutical and medical device segments.

Why interesting to a deal team

Expert advised on major corporate restructuring and spin-off; shows knowledge of large-cap pharma portfolio strategy and public company separation mechanics.

Experts connected to this company

ES

Eric Stewart

Senior Managing Director, European M&A

Leerink Partners

Fund GPLondon

Stewart built Leerink's European healthcare M&A practice from scratch, bringing a decade of Lazard deal relationships spanning Mallinckrodt, Abcam/Danaher and Galderma.

Sources